Related Experiment Video
Updated: Sep 8, 2025

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers
Robert Dood1,2, Britton Trabert3,2, Theresa L Werner2,4
1Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, Utah, USA robdood@gmail.com.
Abstract
No abstract available in PubMed .

